Pages that link to "Q310543"
Jump to navigation
Jump to search
The following pages link to Clostridium difficile (Q310543):
Displayed 50 items.
- Firmicutes (Q149075) (← links)
- antibiotic-associated diarrhea (Q574891) (← links)
- Clostridioides difficile colitis (Q574905) (← links)
- Clostridium difficile toxin B (Q5135489) (← links)
- Peptoclostridium difficile 630 (Q21102976) (← links)
- Clostridium difficile phages: still difficult? (Q21131097) (← links)
- The repetitive oligopeptide sequences modulate cytopathic potency but are not crucial for cellular uptake of Clostridium difficile toxin A (Q21135522) (← links)
- Microevolutionary analysis of Clostridium difficile genomes to investigate transmission (Q21184007) (← links)
- Lactobacillus delbrueckii ssp. bulgaricus B-30892 can inhibit cytotoxic effects and adhesion of pathogenic Clostridium difficile to Caco-2 cells (Q21198789) (← links)
- Reduction of Clostridium Difficile and vancomycin-resistant Enterococcus contamination of environmental surfaces after an intervention to improve cleaning methods (Q21261741) (← links)
- Clostridium difficile 630 (Q21397905) (← links)
- Discovery and Development of NVB302, a Semisynthetic Antibiotic for Treatment of Clostridium difficile Infection (Q22337439) (← links)
- Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children (Q24202700) (← links)
- Antibiotic treatment for Clostridium difficile -associated diarrhea in adults (Q24234378) (← links)
- Fecal transplantation for recurrent or refractory Clostridium difficile diarrhea (Q24234630) (← links)
- Probiotics for the prevention of Clostridium difficile associated diarrhea in adults and children (Q24242732) (← links)
- Probiotics for treatment of Clostridium difficile-associated colitis in adults (Q24242821) (← links)
- Antibiotic treatment for Clostridium difficile-associated diarrhea in adults (Q24244302) (← links)
- Antibiotic treatment for Clostridium difficile-associated diarrhea in adults (Q24244843) (← links)
- Probiotics for the prevention of Clostridium difficile associated diarrhea in adults (Q24245683) (← links)
- Probiotics for Clostridium difficile-associated colitis in adults (Q24247849) (← links)
- Antibiotic treatment for Clostridium difficile-associated diarrhea in adults (Q24247879) (← links)
- Clostridium difficile toxin B induces apoptosis in intestinal cultured cells (Q24522411) (← links)
- Clostridium difficile toxins: mechanism of action and role in disease (Q24522454) (← links)
- Clostridium difficile associated diarrhoea: diagnosis and treatment (Q24531456) (← links)
- In vitro activity of linezolid against Clostridium difficile (Q24535947) (← links)
- Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications (Q24542134) (← links)
- pH-induced conformational changes in Clostridium difficile toxin B (Q24548768) (← links)
- Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa (Q24548845) (← links)
- Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers (Q24561503) (← links)
- Toxins A and B from Clostridium difficile differ with respect to enzymatic potencies, cellular substrate specificities, and surface binding to cultured cells (Q24561508) (← links)
- The low molecular mass GTP-binding protein Rho is affected by toxin A from Clostridium difficile (Q24562382) (← links)
- Rifalazil treats and prevents relapse of clostridium difficile-associated diarrhea in hamsters (Q24563857) (← links)
- Purification and characterization of toxins A and B of Clostridium difficile (Q24604972) (← links)
- Neutrophil recruitment in Clostridium difficile toxin A enteritis in the rabbit (Q24607564) (← links)
- Amixicile, a novel inhibitor of pyruvate: ferredoxin oxidoreductase, shows efficacy against Clostridium difficile in a mouse infection model (Q24616179) (← links)
- Clostridium difficile: its disease and toxins (Q24617347) (← links)
- Surgical Management of Clostridium difficile Colitis (Q24618413) (← links)
- Evolutionary dynamics of Clostridium difficile over short and long time scales (Q24622076) (← links)
- Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003 (Q24627863) (← links)
- Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection (Q24632307) (← links)
- Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon. (Q24632558) (← links)
- Clostridium difficile infection: update on emerging antibiotic treatment options and antibiotic resistance (Q24632641) (← links)
- Treating Clostridium difficile infection with fecal microbiota transplantation (Q24634294) (← links)
- Regulation of toxin synthesis in Clostridium difficile by an alternative RNA polymerase sigma factor (Q24634418) (← links)
- Lipolysis-stimulated lipoprotein receptor (LSR) is the host receptor for the binary toxin Clostridium difficile transferase (CDT) (Q24635365) (← links)
- Application of isothermal helicase-dependent amplification with a disposable detection device in a simple sensitive stool test for toxigenic Clostridium difficile (Q24642390) (← links)
- Bench-to-bedside review: Clostridium difficile colitis (Q24644191) (← links)
- Prospective study of oral teicoplanin versus oral vancomycin for therapy of pseudomembranous colitis and Clostridium difficile-associated diarrhea (Q24644390) (← links)
- Toxin B is essential for virulence of Clostridium difficile (Q24647539) (← links)